Baoxia Dong

1.2k total citations
39 papers, 951 citations indexed

About

Baoxia Dong is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Baoxia Dong has authored 39 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Baoxia Dong's work include Multiple Myeloma Research and Treatments (5 papers), Viral-associated cancers and disorders (5 papers) and Immune Cell Function and Interaction (5 papers). Baoxia Dong is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Viral-associated cancers and disorders (5 papers) and Immune Cell Function and Interaction (5 papers). Baoxia Dong collaborates with scholars based in China, Canada and United States. Baoxia Dong's co-authors include Katherine A. Siminovitch, Xiequn Chen, Jinyi Zhang, Guangxun Gao, Hongjuan Dong, Hongtao Gu, Liang Chen, Ying Gao, Frank Qiu and Alan C. Peterson and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Baoxia Dong

38 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baoxia Dong China 16 470 327 185 159 134 39 951
Takeharu Sakamoto Japan 22 587 1.2× 235 0.7× 307 1.7× 92 0.6× 108 0.8× 54 1.2k
Gayathri Swaminathan United States 13 514 1.1× 211 0.6× 237 1.3× 54 0.3× 144 1.1× 21 898
Shilpee Dutt India 21 902 1.9× 269 0.8× 295 1.6× 130 0.8× 138 1.0× 48 1.5k
Tom Kay Australia 7 932 2.0× 710 2.2× 309 1.7× 79 0.5× 92 0.7× 9 1.6k
Annabelle M. Friera United States 13 580 1.2× 437 1.3× 312 1.7× 269 1.7× 64 0.5× 18 1.1k
Carl P. Simkevich United States 16 751 1.6× 261 0.8× 178 1.0× 84 0.5× 87 0.6× 19 1.1k
José F. Ruiz Spain 17 1.0k 2.2× 101 0.3× 171 0.9× 139 0.9× 100 0.7× 29 1.4k
Niranjan Yanamandra United States 18 441 0.9× 122 0.4× 265 1.4× 155 1.0× 42 0.3× 28 823
Verónica Ayllón Spain 23 1.1k 2.3× 179 0.5× 171 0.9× 209 1.3× 241 1.8× 42 1.4k

Countries citing papers authored by Baoxia Dong

Since Specialization
Citations

This map shows the geographic impact of Baoxia Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoxia Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoxia Dong more than expected).

Fields of papers citing papers by Baoxia Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baoxia Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoxia Dong. The network helps show where Baoxia Dong may publish in the future.

Co-authorship network of co-authors of Baoxia Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Baoxia Dong. A scholar is included among the top collaborators of Baoxia Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baoxia Dong. Baoxia Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Hailong, et al.. (2022). The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects. Journal of Oncology. 2022. 1–12. 9 indexed citations
2.
Shi, Xin, Yanhua Zheng, Li Xu, et al.. (2019). The inflammatory cytokine profile of myelodysplastic syndromes. Medicine. 98(22). e15844–e15844. 33 indexed citations
3.
Jin, Yulong, Li Xu, Xiaodong Wu, et al.. (2019). Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 27(6). 729–737. 16 indexed citations
4.
Reyna, Denis E., Thomas P. Garner, Andrea López, et al.. (2017). Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia. Cancer Cell. 32(4). 490–505.e10. 120 indexed citations
5.
Cao, Chun, Juan Feng, Hongtao Gu, et al.. (2017). Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution. Annals of Diagnostic Pathology. 34. 60–65. 14 indexed citations
6.
Dong, Baoxia, Ally-Khan Somani, Paul E. Love, et al.. (2016). CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1. International Journal of Molecular Medicine. 38(1). 45–56. 10 indexed citations
7.
Liang, Rong, Zhe Wang, Guangxun Gao, et al.. (2016). Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China. Oncology Research and Treatment. 39(1-2). 45–52. 9 indexed citations
8.
9.
10.
Dong, Baoxia, Wen Gao, Jun Chen, et al.. (2013). Mammalian Diaphanous-Related Formin 1 Regulates GSK3β-Dependent Microtubule Dynamics Required for T Cell Migratory Polarization. PLoS ONE. 8(11). e80500–e80500. 19 indexed citations
11.
Pan, Yaozhu, Ying Gao, Liang Chen, et al.. (2011). Targeting Autophagy Augments In Vitro and In Vivo Antimyeloma Activity of DNA-Damaging Chemotherapy. Clinical Cancer Research. 17(10). 3248–3258. 77 indexed citations
12.
Zhang, Jinyi, Naima Zahir, Xianwang Meng, et al.. (2011). The autoimmune disease–associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nature Genetics. 43(9). 902–907. 196 indexed citations
13.
Shi, Yongquan, Jinyi Zhang, Michael Mullin, et al.. (2009). The mDial Formin Is Required for Neutrophil Polarization, Migration, and Activation of the LARG/RhoA/ROCK Signaling Axis during Chemotaxis. The Journal of Immunology. 182(6). 3837–3845. 80 indexed citations
14.
Gao, Guangxun, Liang Chen, Baoxia Dong, et al.. (2009). RhoA effector mDia1 is required for PI 3-kinase-dependent actin remodeling and spreading by thrombin in platelets. Biochemical and Biophysical Research Communications. 385(3). 439–444. 15 indexed citations
15.
Dong, Hongjuan, Liang Chen, Xiequn Chen, et al.. (2009). Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells. Leukemia & lymphoma. 50(6). 974–984. 57 indexed citations
16.
Zhang, Jinyi, Baoxia Dong, & Katherine A. Siminovitch. (2009). Contributions of Wiskott–Aldrich syndrome family cytoskeletal regulatory adapters to immune regulation. Immunological Reviews. 232(1). 175–194. 15 indexed citations
17.
Huang, Gaosheng, Zhe Wang, Xiequn Chen, et al.. (2008). Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR. International Journal of Hematology. 87(2). 152–166. 17 indexed citations
18.
Han, Dongmei, Xiequn Chen, Rong Liang, Baoxia Dong, & Wen Yin. (2006). [Inhibition of proliferation and induction of apoptosis and differentiation of leukemic cell line HL-60 by sodium valproate].. PubMed. 14(1). 21–4. 3 indexed citations
19.
Wang, Zhe, Rong Liang, Gaosheng Huang, et al.. (2006). Glucosamine sulfate–induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL. APOPTOSIS. 11(10). 1851–1860. 21 indexed citations
20.
Dong, Baoxia, et al.. (2001). [Functional assessment of infiltrating immunocytes in patients with primary hepatocellular carcinoma after percutaneous microwave coagulation therapy].. PubMed. 81(16). 974–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeharu Sakamoto Breakdown of academic impact, for papers by Gayathri Swaminathan Breakdown of academic impact, for papers by Shilpee Dutt Breakdown of academic impact, for papers by Tom Kay Breakdown of academic impact, for papers by Annabelle M. Friera Breakdown of academic impact, for papers by Carl P. Simkevich Breakdown of academic impact, for papers by José F. Ruiz Breakdown of academic impact, for papers by Niranjan Yanamandra Breakdown of academic impact, for papers by Verónica Ayllón
Rankless by CCL
2026